PremiumRatingsHold Rating Maintained for American Well Amid Revenue Growth and Contract Uncertainties Amwell backs FY25 revenue view $250M-$260M, consensus $255.06M Amwell reports Q1 EPS ($1.19), consensus ($1.88) PremiumThe FlyTelehealth companies aggressively marketing hair-loss medicine to men, WSJ says Amwell Appoints Dan Zamansky as New CTO Amwell appoints Zamansky as Chief Product, Technology Officer PremiumRatingsStrong Revenue Performance and Strategic Growth: Justifying the Buy Rating for American Well Hold Rating for American Well Amid Mixed Financial Outlook and Strategic Shifts Amwell Reports Improved 2024 Financial Results 
